Poland· PL-100024701
Flucinar N
A fluocinolon acetonid und antibiotika product containing fluocinoloni acetonidum + neomycini sulfas, registered in Poland by Bausch Health Ireland Ltd.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Fluocinolon acetonid und antibiotika is registered in 2 of 19 countries.
Countries holding a registration under ATC D07CC02 (fluocinolon acetonid und antibiotika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Fluocinolon acetonid und antibiotika · ATC D07CC02
2 / 19 countries
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Fluocinoloni acetonidum + Neomycini sulfas
- Manufacturer
- Bausch Health Ireland Ltd.
- Country
- Poland (PL)
- ATC code
- D07CC02
- ATC class
- Fluocinolon acetonid und Antibiotika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990282616
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fluocinolon acetonid und antibiotika in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Bulgaria · Флуцинар N
- Germany · Jellin-Neomycin
- Hungary · Flucinar N
- Italy · Doricum, Localyn
- Lithuania · Flucinar N
- Latvia · Flucinar N
- Portugal · Synalar N
- Romania · Fluocinolon N Atb
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/16f96315-ae3e-4322-9bf4-a21e404c7722 GET /v1/drugs/16f96315-ae3e-4322-9bf4-a21e404c7722?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "(0,25 mg + 5 mg)/g",
"packaging": "05909990282616 ¦ Rp ¦ 3999\n1 op. 15 g",
"substance": "Fluocinoloni acetonidum 0.25 mg/g + Neomycini sulfas 5 mg/g",
"common_name": "Fluocinoloni acetonidum + Neomycini sulfas",
"pl_product_id": "100024701",
"pozwolenie_nr": "02826",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about fluocinolon acetonid und antibiotika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.